Vice President, Market Access
Paolo Morgese brings over 15 years of expertise in market access and pricing.
After working at Kyphon, a health technology assessment agency and with Merck Serono in health economics and market access roles, Paolo joined the healthcare investment fund Deerfield Management as EU Director of Research in 2012. He set up market access research activities and led the European Equity Research team during his five-year tenure.
In 2017, Paolo founded Forethought Access, a boutique market access consultancy focusing on early-stage market access in relation to financing/investment activities.
Paolo holds the position of EU Director of Market Access at the Alliance for Regenerative Medicine and is a recognized expert on market access of Advanced Therapies.
Paolo holds a Laurea in Economics from the University of Siena (IT) and MSc in Financial and Business Economics from the University of Essex (UK).